IMMUNOMODULATION BY ENZYME IL4I1

ERGANEO



23 Juillet 2020

Partager sur facebook Partager sur twitter Partager sur linkedin Partager sur google+

Fields

Biology / Medical

Sectors

Health

IL4I1 is an immunosuppressive enzyme highly expressed in all cancers by infiltrating macrophages and in some cases, such as B lymphomas and mesotheliomas, by tumor cells. Its expression in the tumor bed favors immune escape. This process might result in a defective response to immunotherapy in cancers, in particular in the cases, which have failed or become resistant to anti-checkpoint treatments. We propose specific inhibitors of enzyme IL4I1 to enhance the anti-tumor immune response.

Competitive advantages:

  • Efficient inhibitors of IL4I1
  • Non toxic

Applications:

  • All types of cancers presenting a macrophage infiltrate
  • Melanoma
  • Lymphoma
  • Mesothelioma

Keywords: Cancer, Anti-tumor, Immunomodulation, Immunosuppressive enzyme, IL4I1, Immunotherapy

Download the offer Download the offer

Newsletter